ORUKA THERAPEUTICS INC(ORKA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ORKA ORUKA THERAPEUTICS INC

盘后交易 02-23 18:48:44 EST

33.32

+0.98

+3.03%

盘后33.32

+0.000.00%

17:16 EST

最高33.99	最低32.22	成交量24.06万
今开32.49	昨收32.34	日振幅5.47%
总市值16.13亿	流通市值7.47亿	总股本4,841万
成交额800.85万	换手率1.07%	流通股本2,241万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":33.32,"timestamp":1771880400000,"preClose":32.34,"halted":0,"volume":240573,"hourTrading":{"tag":"盘后","latestPrice":33.32,"preClose":33.32,"latestTime":"17:16 EST","volume":9125,"amount":304049.589875,"timestamp":1771884983649,"change":0,"changeRate":0,"amplitude":0.001801},"delay":0,"changeRate":0.030303030303030203,"floatShares":22408091,"shares":48409232,"eps":-2.3625,"marketStatus":"盘后交易","change":0.98,"latestTime":"02-23 18:48:44 EST","open":32.49,"high":33.99,"low":32.22,"amount":8008545.26058,"amplitude":0.054731,"askPrice":35,"askSize":100,"bidPrice":32.67,"bidSize":61,"shortable":3,"etf":0,"ttmEps":-2.3625,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771894800000},"marketStatusCode":4,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":32.34,"preHourTrading":{"tag":"盘前","latestPrice":32.1797,"preClose":32.34,"latestTime":"09:27 EST","volume":2,"amount":64.2297,"timestamp":1771856870073,"change":-0.1603,"changeRate":-0.004957,"amplitude":0.004011},"postHourTrading":{"tag":"盘后","latestPrice":33.32,"preClose":33.32,"latestTime":"17:16 EST","volume":9125,"amount":304049.589875,"timestamp":1771884983649,"change":0,"changeRate":0,"amplitude":0.001801},"volumeRatio":0.835461,"impliedVol":0.9239,"impliedVolPercentile":0.5261},"requestUrl":"/m/hq/s/ORKA","defaultTab":"news","newsList":[{"id":"2602323961","title":"Oruka Therapeutics, Inc.盘中异动 股价大跌5.03%报26.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602323961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602323961?lang=zh_cn&edition=full","pubTime":"2026-01-09 02:23","pubTimestamp":1767896601,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日02时23分，Oruka Therapeutics, Inc.股票出现波动，股价大幅下挫5.03%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109022322a4ad0021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109022322a4ad0021&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2586130172","title":"开山股份(300257.SZ)子公司KS ORKA与匈牙利合作伙伴签订合资意向书 拟共同推进地热发电项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2586130172","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586130172?lang=zh_cn&edition=full","pubTime":"2025-11-27 12:00","pubTimestamp":1764216026,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开山股份 发布公告，近日，公司全资子公司KS ORKA Renewables Pte Ltd与匈牙利公司BlényZrt等合作方共同签署了《合资意向书》，计划共同出资设立合资公司，旨在共同推进匈牙利的地热发电项目。在《合资意向书》签署之时，Blény正在筹建一个具有官方背景、专注于能源领域的混合基金。在BEF成立后，Blény将指定BEF成为合资公司的股东，并签署相关协议。与Blény、BEF的合作，将为公司深度拓展匈牙利乃至中东欧能源市场构建一个重要平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK0117","ORKA","300257","BK0196","BK4139","BK0259","BK0188"],"gpt_icon":0},{"id":"2583357625","title":"Oruka Therapeutics, Inc.盘中异动 早盘股价大涨5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583357625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583357625?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:38","pubTimestamp":1762958337,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时38分，Oruka Therapeutics, Inc.股票出现波动，股价急速上涨5.85%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112223858a6f4b748&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112223858a6f4b748&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","BK4539","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2569530257","title":"Oruka Therapeutics, Inc.盘中异动 急速上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569530257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569530257?lang=zh_cn&edition=full","pubTime":"2025-09-22 23:21","pubTimestamp":1758554487,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日23时21分，Oruka Therapeutics, Inc.股票出现波动，股价大幅上涨5.21%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Mbx Biosciences, Inc.、Qualigen Therapeutics, Inc.、Metsera, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Mbx Biosciences, Inc.较为活跃，换手率分别为2777.25%、150.36%、59.73%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Kodiak Sciences Inc，振幅分别为114.44%、64.50%、42.92%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922232127953e1b7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922232127953e1b7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ORKA","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"1122709697","title":"Oruka Therapeutics股价飙升20%创八个月新高，实验性银屑病药物早期研究获积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1122709697","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122709697?lang=zh_cn&edition=full","pubTime":"2025-09-17 21:37","pubTimestamp":1758116240,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics股价大涨20%，达到八个月以来的最高水平。该公司宣布其实验性银屑病治疗药物的早期阶段研究获得积极结果，推动股价强劲上扬。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORKA"],"gpt_icon":0},{"id":"1113250817","title":"ORUKA THERAPEUTICS INC宣布完成1.8亿美元私募融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1113250817","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113250817?lang=zh_cn&edition=full","pubTime":"2025-09-17 13:03","pubTimestamp":1758085412,"startTime":"0","endTime":"0","summary":"加利福尼亚州门洛帕克，2025年9月17日——专注于开发创新生物制剂以治疗慢性皮肤疾病的生物技术公司ORUKA THERAPEUTICS INC今日宣布，公司已签署证券购买协议，进行私募股权投资融资，预计将为公司带来约1.8亿美元的总收益，扣除承销费用和发行费用前。此次PIPE融资由Viking Global Investors牵头，新老投资者均有参与，包括Affinity Healthcare Fund、Blackstone Multi-Asset Investing、Commodore Capital、Cormorant Asset Management、Deep Track Capital、Fairmount、Great Point Partners LLC、Palo Alto Investors LP、Perceptive Advisors、Surveyor Capital、Venrock Healthcare Capital Partners、Woodline Partners LP以及一支领先的生命科学投资基金等。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","BK4539","ORKA","BK4007"],"gpt_icon":0},{"id":"2518628979","title":"Oruka Therapeutics, Inc.2024财年实现净利润-83.72百万美元，同比减少1467.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518628979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518628979?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536084,"startTime":"0","endTime":"0","summary":"3月10日，Oruka Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-83.72百万美元，同比减少1467.79%；其中营业收入为0.00美元，每股基本收益为-4.99美元。机构评级：截至2025年3月10日，当前有7家机构对Oruka Therapeutics, Inc.目标价做出预测，其中目标均价为39.86美元，其中最低目标价为20.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000310a268989d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000310a268989d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ORKA"],"gpt_icon":0},{"id":"2517147141","title":"Oruka Therapeutics(ORKA.US)：2024年Q4财报实现营收0美元；每股收益为-0.49美元，预期值为-0.98美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517147141","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517147141?lang=zh_cn&edition=full","pubTime":"2025-03-07 07:03","pubTimestamp":1741302186,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics(ORKA.US)：2024年Q4财报实现营收0美元；每股收益为-0.49美元，预期值为-0.98美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07070348578859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ORKA","LENZ"],"gpt_icon":0},{"id":"1179465603","title":"Oruka Therapeutics 2024年第四季度GAAP每股收益$(0.49)优于$(0.79)预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1179465603","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179465603?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:26","pubTimestamp":1741296399,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics（LENZ）2024年第四季度GAAP每股收益为$(0.49)，优于$(0.79)的市场预期。以上内容来自Benzinga Earnings专栏，原文如下：Oruka $Therapeutics(LENZ)$ Q4 2024 GAAP EPS $(0.49) Beats $(0.79) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA","LENZ"],"gpt_icon":0},{"id":"2514830378","title":"Oruka Therapeutics, Inc.盘中异动 早盘大幅拉升6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514830378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514830378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753080,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Oruka Therapeutics, Inc.股票出现波动，股价快速上涨6.54%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Anaptysbio, Inc.、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为480.35%、239.11%、55.70%，振幅较大的相关个股有Trevi Therapeutics, Inc.、Enanta Pharmaceuticals, Inc.、Aardvark Therapeutics, Inc.，振幅分别为7.11%、6.58%、6.22%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223120abe0ea11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223120abe0ea11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ORKA"],"gpt_icon":0},{"id":"2514988332","title":"Oruka Therapeutics, Inc.盘中异动 股价大跌5.03%报10.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514988332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514988332?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:20","pubTimestamp":1740687649,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时20分，Oruka Therapeutics, Inc.股票出现波动，股价急速下跌5.03%。截至发稿，该股报10.00美元/股，成交量24.6738万股，换手率0.70%，振幅7.12%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228042050abdfbab6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228042050abdfbab6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","LENZ","BK4139"],"gpt_icon":0},{"id":"2509466097","title":"Oruka Therapeutics, Inc.盘中异动 早盘股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509466097?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:15","pubTimestamp":1738685753,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时15分，Oruka Therapeutics, Inc.股票出现波动，股价快速拉升5.40%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Evaxion Biotech As涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1630.09%、925.32%、453.14%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、49.88%、47.29%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001553a2393cfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001553a2393cfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ORKA"],"gpt_icon":0},{"id":"2507678187","title":"Oruka Therapeutics, Inc.盘中异动 急速上涨5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507678187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507678187?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:05","pubTimestamp":1738253124,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时05分，Oruka Therapeutics, Inc.股票出现异动，股价大幅上涨5.97%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1600.16%、212.94%、197.28%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ，振幅分别为61.86%、61.86%、56.41%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013100052496144847&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013100052496144847&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ORKA"],"gpt_icon":0},{"id":"2505271998","title":"Oruka Therapeutics, Inc.盘中异动 早盘股价大涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505271998?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:31","pubTimestamp":1737469889,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时31分，Oruka Therapeutics, Inc.股票出现波动，股价快速拉升5.96%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Dogwood Therapeutics, Inc.、Replimune Group, Inc.、Allakos Inc.涨幅较大，Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为515.43%、161.03%、26.98%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Allakos Inc.、Equillium, Inc.，振幅分别为140.64%、111.05%、107.00%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。它为患有斑块状牛皮癣等慢性皮肤病的患者提供服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223129986e32c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223129986e32c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORKA","LENZ"],"gpt_icon":0},{"id":"2503188019","title":"Oruka Therapeutics, Inc.盘中异动 早盘股价大涨6.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503188019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503188019?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:31","pubTimestamp":1737037918,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时31分，Oruka Therapeutics, Inc.股票出现波动，股价快速上涨6.26%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aditxt, Inc.、Cytomed Therapeutics Limited涨幅较大，Aditxt, Inc.、Palisade Bio, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为976.84%、334.72%、194.06%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Aditxt, Inc.、Onconetix, Inc.，振幅分别为21.79%、12.06%、9.03%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223158a2245fa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223158a2245fa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","LENZ","BK4139"],"gpt_icon":0},{"id":"2500112689","title":"Oruka Therapeutics, Inc.盘中异动 早盘快速下挫7.86%报18.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500112689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500112689?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:30","pubTimestamp":1735914659,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时30分，Oruka Therapeutics, Inc.股票出现波动，股价急速下跌7.86%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为843.25%、450.51%、254.33%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.、Oculis Holding Ag C/Wts 06/03/2028 ，振幅分别为20.87%、14.34%、7.60%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010322305995f7d19d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010322305995f7d19d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ORKA"],"gpt_icon":0},{"id":"2491328375","title":"Oruka Therapeutics, Inc.盘中异动 大幅拉升5.07%报22.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491328375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491328375?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:34","pubTimestamp":1734100489,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时34分，Oruka Therapeutics, Inc.股票出现异动，股价急速拉升5.07%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Oculis Holding Ag C/Wts 06/03/2028 、Barinthus Biotherapeutics Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为26.10%、21.62%、16.58%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Oculis Holding Ag C/Wts 06/03/2028 、Innate Pharma，振幅分别为30.24%、20.93%、19.35%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322345095e976d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322345095e976d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORKA","LENZ"],"gpt_icon":0},{"id":"2486494886","title":"Oruka Therapeutics, Inc.盘中异动 股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486494886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486494886?lang=zh_cn&edition=full","pubTime":"2024-11-27 00:47","pubTimestamp":1732639644,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日00时47分，Oruka Therapeutics, Inc.股票出现异动，股价快速上涨5.73%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Poseida Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Ventyx Biosciences, Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃，换手率分别为42.96%、29.76%、24.03%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Protagenic Therapeutics, Inc.，振幅分别为85.82%、57.50%、42.94%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127004725971a8afb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127004725971a8afb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","BK4139","LENZ"],"gpt_icon":0},{"id":"2486803167","title":"Oruka Therapeutics, Inc.盘中异动 早盘股价大跌6.00%报19.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486803167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486803167?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:05","pubTimestamp":1732550751,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日00时05分，Oruka Therapeutics, Inc.股票出现波动，股价急速下跌6.00%。截至发稿，该股报19.51美元/股，成交量9.8042万股，换手率0.28%，振幅7.98%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112600055198e44747&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112600055198e44747&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ORKA","BK4139"],"gpt_icon":0},{"id":"2485829872","title":"Oruka Therapeutics, Inc.2024财年第三财季实现净利润-28.62百万美元，同比减少1915.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485829872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485829872?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291303,"startTime":"0","endTime":"0","summary":"11月23日，Oruka Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-28.62百万美元，同比减少1915.49%；其中营业收入为0.00美元，每股基本收益为-1.91美元。机构评级：截至2024年11月23日，当前有6家机构对Oruka Therapeutics, Inc.目标价做出预测，其中目标均价为43.17美元，其中最低目标价为40.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000203a24e490b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000203a24e490b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ORKA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://orukatx.com","stockEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":-0.0615},{"period":"3month","weight":0.1041},{"period":"6month","weight":1.0952},{"period":"1year","weight":1.867},{"period":"ytd","weight":0.067}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Oruka Therapeutics, Inc.公司根据日期为2008年9月24日的协议和合并重组计划的条款完成了与ARCA Colorado的业务合并（合并），并于2008年10月28日进行了修订，其中Nuvelo，Inc.的全资子公司与ARCA Colorado合并，ARCA Colorado在合并后继续作为存续公司和Nuvelo，Inc.的全资子公司。紧随合并后，该公司从Nuvelo，Inc.更名为ARCA Biopharma，Inc.。Nuvelo最初注册成立为HYSEQ。该公司是一家临床阶段的生物制药公司，专注于开发针对银屑病、炎症和免疫学适应症的新型单克隆抗体疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.352941,"avgChangeRate":0.043718},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.073439},{"month":3,"riseRate":0.352941,"avgChangeRate":-0.027833},{"month":4,"riseRate":0.588235,"avgChangeRate":0.096272},{"month":5,"riseRate":0.529412,"avgChangeRate":0.094017},{"month":6,"riseRate":0.294118,"avgChangeRate":0.450356},{"month":7,"riseRate":0.529412,"avgChangeRate":0.025688},{"month":8,"riseRate":0.117647,"avgChangeRate":-0.132304},{"month":9,"riseRate":0.352941,"avgChangeRate":-0.05799},{"month":10,"riseRate":0.470588,"avgChangeRate":-0.023177},{"month":11,"riseRate":0.647059,"avgChangeRate":0.007168},{"month":12,"riseRate":0.529412,"avgChangeRate":-0.002826}],"exchange":"NASDAQ","name":"ORUKA THERAPEUTICS INC","nameEN":"ORUKA THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ORUKA THERAPEUTICS INC(ORKA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ORUKA THERAPEUTICS INC(ORKA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ORUKA THERAPEUTICS INC,ORKA,ORUKA THERAPEUTICS INC股票,ORUKA THERAPEUTICS INC股票老虎,ORUKA THERAPEUTICS INC股票老虎国际,ORUKA THERAPEUTICS INC行情,ORUKA THERAPEUTICS INC股票行情,ORUKA THERAPEUTICS INC股价,ORUKA THERAPEUTICS INC股市,ORUKA THERAPEUTICS INC股票价格,ORUKA THERAPEUTICS INC股票交易,ORUKA THERAPEUTICS INC股票购买,ORUKA THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ORUKA THERAPEUTICS INC(ORKA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ORUKA THERAPEUTICS INC(ORKA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}